(Q28294949)

1

0 references

Di Wang

2

0 references

Hongyan Zhang

3

0 references

Chunyu Wang

4

0 references

Wei Dai

5

0 references

Zhenguo Cheng

6

0 references

Guanqiao Wang

7

0 references

Feng Li

Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates with a transformed phenotype in breast cancer cells

8

0 references

language of work or name

English

0 references

publication date

October 2013

0 references

published in

The Anatomical Record

0 references

volume

296

0 references

issue

10

0 references

page(s)

1561-7

0 references

cites work

1 reference

Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma.

21 January 2018

1 reference

CDK inhibitors: cell cycle regulators and beyond

21 January 2018

1 reference

p57Kip2 is a downstream effector of BCR-ABL kinase inhibitors in chronic myelogenous leukemia cells.

21 January 2018

1 reference

Pak4 induces premature senescence via a pathway requiring p16INK4/p19ARF and mitogen-activated protein kinase signaling

21 January 2018

1 reference

Copy number alterations in pancreatic cancer identify recurrent PAK4 amplification

21 January 2018

1 reference

MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma

21 January 2018

1 reference

MEK-ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes

21 January 2018

1 reference

Downregulation of p57 accelerates the growth and invasion of hepatocellular carcinoma

21 January 2018

1 reference

The p57 CDKi integrates stress signals into cell-cycle progression to promote cell survival upon stress

21 January 2018

1 reference

p57(KIP2) control of actin cytoskeleton dynamics is responsible for its mitochondrial pro-apoptotic effect.

21 January 2018

1 reference

Myc-induced microRNAs integrate Myc-mediated cell proliferation and cell fate

21 January 2018

1 reference

p21-activated kinases in cancer

21 January 2018

1 reference

CDKN1C/p57kip2 is a candidate tumor suppressor gene in human breast cancer

21 January 2018

1 reference

PAK as a therapeutic target in gastric cancer

21 January 2018

1 reference

Nucleo-cytoplasmic shuttling of PAK4 modulates β-catenin intracellular translocation and signaling

21 January 2018

1 reference

The pak4 protein kinase plays a key role in cell survival and tumorigenesis in athymic mice

21 January 2018

1 reference

Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors

21 January 2018

1 reference

PAK4 is required for regulation of the cell-cycle regulatory protein p21, and for control of cell-cycle progression

21 January 2018

1 reference

p57KIP2: "Kip"ing the cell under control.

21 January 2018

1 reference

Activated PAK4 regulates cell adhesion and anchorage-independent growth

21 January 2018

1 reference

p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients

21 January 2018

1 reference

Akt and ERK control the proliferative response of mammary epithelial cells to the growth factors IGF-1 and EGF through the cell cycle inhibitor p57Kip2.

21 January 2018

1 reference

CDKN1C (p57) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells

21 January 2018

1 reference